ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) Return on equity 2020–2025
ARCUTIS BIOTHERAPEUTICS, INC. (ARQT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-8.5%FY2025 · since FY2020: -50.1% → -8.5%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -8.5% | +80.4 pp |
| FY2024 | -88.9% | +206.8 pp |
| FY2023 | -295.6% | -147.0 pp |
| FY2022 | -148.6% | -79.3 pp |
| FY2021 | -69.3% | -19.2 pp |
| FY2020 | -50.1% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice